Corvus Pharmaceuticals (CRVS) Other Operating Expenses (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Other Operating Expenses of $4.2 million for Q1 2026, up 544.82% year-over-year from $652584.9 in Q1 2025, and up 782.01% quarter-over-quarter from -$617000.0 in Q3 2025.
Corvus Pharmaceuticals (CRVS) Other Operating Expenses (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 544.82% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $2.7 million (up 220.68% YoY), while the FY2022 annual figure was $22000.0, changed N/A from the prior year.
- Other Operating Expenses for Q1 2026 stood at $4.2 million, up from -$617000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $4.2 million in Q1 2026, with the low at -$946000.0 in Q1 2025.
- The 3-year median for Other Operating Expenses is -$617000.0 (2025), against an average of $412285.7.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses plunged 139.16% in 2025, then surged 544.82% in 2026.
- Corvus Pharmaceuticals' Other Operating Expenses stood at -$776000.0 in 2024, then gained by 20.49% to -$617000.0 in 2025, then soared by 782.01% to $4.2 million in 2026.
- Business Quant data shows CRVS's Other Operating Expenses at $4.2 million in Q1 2026, -$617000.0 in Q3 2025, and -$848000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.15 Mn |
| Mar 31, 2026 | 4.21 Mn |
| Sep 30, 2025 | -617,000.00 |
| Jun 30, 2025 | -848,000.00 |
| Mar 31, 2025 | -946,000.00 |
| Sep 30, 2024 | -776,000.00 |
| Jun 30, 2024 | -551,000.00 |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2017 | 46.03 Mn |
| Dec 31, 2016 | -1,000.00 |
| Dec 31, 2015 | 11.34 Mn |